| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |